Peguero-Lo Presti Index Calculator

Clinical calculation support · Verify results before clinical use

Deepest S wave measured in any standard 12-lead ECG lead.
Amplitude of the S wave measured in lead V4.
Patient sex

Formula

The Peguero–Lo Presti index is calculated by adding the amplitude of the deepest S wave in any lead to the amplitude of the S wave in lead V4.

Sdeepest + SV4

The result is expressed in millivolts (mV). With standard ECG calibration, 10 mm corresponds to 1 mV.

Sex-specific thresholds

The original Peguero–Lo Presti criterion uses sex-specific voltage thresholds.

Sex ECG-LVH threshold Equivalent at 10 mm/mV
Male ≥ 2.8 mV ≥ 28 mm
Female ≥ 2.3 mV ≥ 23 mm

Clinical context

The Peguero–Lo Presti criterion is an electrocardiographic voltage criterion developed for the detection of left ventricular hypertrophy. Subsequent studies have compared its diagnostic performance with conventional ECG criteria including Sokolow–Lyon and Cornell voltage criteria.


Meta-analytic evidence suggests that Peguero–Lo Presti may provide higher sensitivity than several conventional voltage criteria while retaining useful specificity. However, diagnostic performance varies across populations and clinical settings.

Measurement considerations

Measurements should be obtained from a properly calibrated standard 12-lead ECG. The deepest S wave should be identified across the available ECG leads, while SV4 refers specifically to the S wave amplitude in lead V4.


At a standard calibration of 10 mm/mV, the male threshold of 2.8 mV corresponds to 28 mm and the female threshold of 2.3 mV corresponds to 23 mm.

Limitations

The Peguero–Lo Presti index is an ECG-based criterion and should not be interpreted as a direct measurement of left ventricular mass.


ECG voltage can be affected by body habitus, lead placement, conduction abnormalities and other clinical factors. A positive result does not independently establish anatomical LVH, while a negative result does not exclude it.

When clinically indicated, structural assessment with echocardiography or cardiac magnetic resonance should be considered for evaluation of left ventricular hypertrophy and left ventricular mass.

References

1. Peguero JG, Lo Presti S, Perez J, Issa O, Brenes JC, Tolentino A. Electrocardiographic Criteria for the Diagnosis of Left Ventricular Hypertrophy. J Am Coll Cardiol. 2017;69(13):1694-1703. PMID: 28359515.

2. Noubiap JJ, Agbaedeng TA, Kamtchum-Tatuene J, et al. A meta-analytic evaluation of the diagnostic accuracy of the electrocardiographic Peguero-Lo Presti criterion for left ventricular hypertrophy. J Clin Hypertens. 2020;22(7):1145-1153. doi: 10.1111/jch.13923. PMID: 32608577.

3. Subsequent validation studies have evaluated the Peguero–Lo Presti criterion in different cardiovascular and hypertensive populations.